Ignite Creation Date:
2024-05-06 @ 1:42 PM
Last Modification Date:
2024-10-26 @ 1:19 PM
Study NCT ID:
NCT04107207
Status:
COMPLETED
Last Update Posted:
2020-07-30
First Post:
2019-09-01
Brief Title:
Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
Sponsor:
Georgetown University
Organization:
Georgetown University
Study Overview
Official Title:
Pilot Study to Evaluate Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
Status:
COMPLETED
Status Verified Date:
2020-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This studys primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II The secondary objective is to determine the ability of Kombucha to impact blood pressure and quality of life measures as measured by uniform questionnaire that includes gut health colds infections headaches sleep anxiety GAD2 depression PHQ2 skin health
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None